Home
Join The Club
Mason (Skip) Irving, III
Partner and Managing Director
Health Advances
Skip is a Partner and Managing Director of Health Advances, LLC, a 60-person, healthcare product-focused, management consulting firm based in Weston, Mass. Skip has spent the last 20 years advising companies on business strategy, technology commercialization, and partnering in the medical products industries.
Prior to joining Health Advances, as Vice President for Commercial Development at the Massachusetts Biotechnology Research Institute (MBRI), Skip was involved in the founding of seven life sciences companies.
Prior to MBRI, Skip was Vice President and Director of Worldwide Healthcare Consulting at Arthur D. Little, Inc. where his professional work involved technology planning, R&D management, and strategic alliances. Working from ADL’s Brussels office, Skip founded ADL’s European Pharmaceutical Practice. Skip also worked for Astra Pharmaceutical Products, Inc. Skip graduated from the Massachusetts College of Pharmacy and earned his MBA at the Amos Tuck School at Dartmouth College.
Ryan Drant
General Partner
New Enterprise Associates
Ryan joined NEA in 1996, and became a General Partner in 2004. He specializes in healthcare
investments in the specialty pharma, medical device and healthcare information technology
sectors. Present board memberships include BENU, Carticept Medical, Concentric Medical,
ExploraMed III, ForHealth Technologies, Intrinsic Therapeutics, Neotract, PatientKeeper,
Simplex Diabetic Supply, Spine Wave, Viacor and Vibrynt. Ryan also co-manages NEA’s
investment in TriVascular2.
Past board memberships include ESP Pharma (acquired by Protein Design Labs, Inc.), Esprit
Pharma (acquired by Allergan), FoxHollow Technologies (NASDAQ: FOXH), Provation Medical
(acquired by Wolters Kluwer), and Proxima Therapeutics (acquired by Cytyc Corporation), and
Ryan co-led NEA’s investment in Xcel Pharmaceuticals (acquired by Valeant Pharmaceuticals,
Inc.).
Prior to joining NEA, Ryan was with the Health Care Investment Banking Group of Alex.
Brown & Sons in San Francisco. Previously, he worked in the San Francisco office of Arthur
Andersen & Co. Ryan received a BA from Stanford University.
Bernadette (Bonnie) C. Fendrock
President and CEO
Hepregen
Ms. Fendrock is co-founder, president, and CEO of Hepregen. Ms. Fendrock comes to Hepregen with more than 20 years of commercial experience in the life sciences industry. As vice president at Genzyme Corporation, Ms. Fendrock was responsible for the commercial planning and market launch of biosurgical products to treat post-operative adhesions. Prior to Genzyme, Ms. Fendrock held positions as director of business development, Somatix, Inc., a start-up gene therapy company, and project manager, Genetics Institute (now Wyeth). Ms. Fendrock also has been a business consultant for the Harvard-MIT Division of Health Sciences and Technology and the Biomedical Enterprise Program (a collaboration with The Sloan School at MIT) and Acusphere, Inc. Ms. Fendrock holds a BA degree with a major in molecular biology from Wellesley College, an SM degree from MIT in interdisciplinary science and an MBA from The Wharton School of the University of Pennsylvania.
Jeffrey Levin-Scherz
Principal
Towers Perrin
Jeff Levin-Scherz is a Principal in the Care Management Practice of Towers Perrin, where he is the clinical lead on projects to improve employee health and increase cost effectiveness through innovative programs, rigorous analytics, and effective incentive programs. He also leads global and domestic business strategy projects including forecasting and scenario planning, and has led development of dashboard metrics.
Dr. Levin-Scherz is also an Assistant Professor at Harvard Medical School and the School of Public Health, where he has taught a semester course, “Managing Heath Care Costs,” for the past six years. He is a frequent speaker on health care policy issues around the country, has served on numerous national committees to assess or improve quality or efficiency of care, and his work has been published in numerous professional journals.
Dr. Levin-Scherz graduated from Boston University School of Medicine and completed his residency at Mount Auburn Hospital in Cambridge, Mass. He is board certified in Internal Medicine, and a Fellow of the American College of Physicians. He completed his MBA at Columbia Business School.
Tom McKinley
General Partner
Cardinal Partners
Tom is the West Coast Representative. Prior to joining Cardinal, Tom was Co-Founder and Co-Managing Partner of Partech International. Tom has over 30 years of investment experience with a track record of helping entrepreneurs create significant and successful enterprises. His investments include Ascend Communications (ASND acquired by Lucent Technologies), Automated Healthcare (acquired by McKesson), Medicode (acquired by United Healthcare) and VISICU (EICU acquired by Philips). He is currently serving as a board of director of TelaDoc, a telehealth services providing doctor consults to consumer.
Tom has served on the boards of U.C. Berkeley's Entrepreneurs Forum and the Western Association of Venture Capitalists (WAVC). He is an active member of the Health Management Academy (HMA) and an active supporter of the University of San Francisco's Entrepreneurship Program. As an alumnus, Tom maintains close ties with Stanford's Business School, as well as Harvard University, where he serves as class secretary and started the I3 Harvard College Innovation Challenge (undergraduate business plan competition).
Tom received an undergraduate degree in Economics from Harvard University, an MS in Accounting from New York University and an MBA from Stanford Graduate School of Business.
John D. Halamka
CIO
Beth Israel Deaconess Medical Center
John Halamka is Chief Information Officer of Beth Israel Deaconess Medical Center, Chief Information Officer of Harvard Medical School, Chairman of the New England Healthcare Exchange Network (NEHEN), Chair of the US Healthcare Information Technology Standards Panel (HITSP), co-Chair of the HIT Standards Committee, and a practicing Emergency Physician.
As Chief Information Officer of Beth Israel Deaconess Medical Center, he is responsible for all clinical, financial, administrative and academic information technology serving 3000 doctors, 14000 employees and two million patients. As Chief Information Officer of Harvard Medical School, he oversees all educational, research and administrative computing for 18000 faculty and 3000 students. As Chairman of NEHEN he oversees clinical and administrative data exchange in Massachusetts. As Chair of HITSP/co-Chair of the HIT Standards Committee he coordinates the process of electronic standards harmonization among stakeholders nationwide.
William O’Leary
Executive Director Health and Human Services
Microsoft Corporation
William D. O’Leary is Executive Director of Health and Human Services (HHS) for Microsoft
Corporation. He directs the Connected Health and Human Services business and IT
strategy across state, and local markets. He is responsible for the subject expertise, business
development and thought leadership of Microsoft Health and Human Services. He coordinates
the Microsoft American Recovery and Reinvestment Act strategy concerning state cooperative
agreement grants, medical homes, regional extension centers, and state Medicaid Health
Information Technology plans. He has authored Microsoft’s Connected Health and Human
Services Business and Architecture Vision, a roadmap to develop consumer centered services
across state, city governments and service providers.
O’Leary’s publications and presentations include “From Urgency to Innovation” (Stewards
of Change/Yale School of Management, January, 2010); “Stimulating Connected Health
and Human Services”, (American Pubic Human Services Association Information Systems
Management, 2009); “Achieving the Consumer Centered, Connected Health and Human
Service Vision” (Stewards of Change/Yale October, 2007); “Hope for Human Services” (Public
CIO, February, 2006); and, “State Governments: Laboratories for Next-generation Health IT”
(Government Health IT Magazine, June 2006).
The former Secretary of Health and Human Services in Massachusetts, O’Leary was responsible
for a $9 billion budget, and oversight of fifteen agencies. He co-chaired the Massachusetts
Health Care Task Force. He developed MassCares; a comprehensive technology based initiative
to better integrate service delivery to children and families. He implemented the most dramatic
expansion of Medicaid and Children’s Health Insurance coverage in the country, resulting at
the time, in less than a 5% uninsured rate for children.
The former state Commissioner of the Department of Youth Services, he developed a
comprehensive community based system of services and supervision. He was a principal in
the development of sweeping juvenile court reform.
An attorney, and graduate of Western New England College School of Law, O’Leary holds a
Masters degree from the School of Criminal Justice at the State University of New York in
Albany, and a Bachelor in Arts degree from the University of Massachusetts. He is a former
court monitor for the Massachusetts Supreme Judicial Court regarding a comprehensive
consent decree involving corrections,education, health and human services. He is former
Deputy Director of the Crime and Justice Foundation. He has served as consultant to the
United States Justice Department, and numerous states regarding development of health,
human service, and criminal justice systems.
Emad Rizk
President, McKesson Health Solutions
McKesson Corporation
As President of the Health Solutions business within McKesson Corporation, a Fortune 50 provider of healthcare products and services, Dr. Emad Rizk is responsible for directing the company’s healthcare payer business, working collaboratively with other business units to provide a broad spectrum of services and products to the commercial and government markets. In this role, Dr. Rizk leads McKesson’s thought leadership in the healthcare market, promoting connectivity and collaboration across healthcare settings. In May 2008, Dr. Rizk was named among the country’s “50 Most Powerful Physician Executives” by Modern Healthcare and Modern Physician magazines.
Since Dr. Rizk assumed this newly-created position in 2003, McKesson Health Solutions has grown by more than 30 percent in revenue and currently serves 600 payers, 3500 hospitals, 47 QIOs, CMS (Medicare), Medicaid, Veterans Administration, and Department of Defense. The divisions principal areas of activity are disease management, clinical decision support, claims performance management, business intelligence, and serving as the largest provider of call center triage services in the US.
Prior to joining McKesson in 2003, Dr. Rizk served as a Partner with Deloitte Consulting, managing and leading the company’s global medical management practice; and Vice President of Medical Operations and Chief Medical Officer with Health Management Associates, with responsibility for the overall direction and management of clinical activities. He was Vice Chairman of the National Clinical Advisory Board and serves on numerous boards, including the Disease Management Association of America and the American Journal of Medical Quality.
Sue Schade
VP and CIO
Brigham and Women's Hospital
Sue Schade serves as the Vice President and Chief Information Officer for Brigham and Women's/Faulkner Hospitals in Boston, Massachusetts, a position she assumed in January of 2000. Schade has 25 years experience in health care information technology management. Her experience includes 12 years in positions of increasing management responsibility at a large integrated delivery system in the Chicago area. Following that, she led the software division for a start-up healthcare software and outsourcing services vendor. Prior to coming to the Boston area, Schade worked as a senior manager in the health care information technology practice at Ernst and Young.
An active member of both HIMSS and CHIME, Schade served on the CHIME Board from 2004 to 2006. She was responsible for their Advocacy initiatives focusing on the national healthcare information technology agenda and fostering CHIME’s partnerships with other national organizations. She chaired the CHIME Education Foundation Board from 2006 to 2009. She is presently serving on the HIMSS Advocacy and Public Policy Steering Committee.
Schade holds an MBA degree from Illinois Benedictine College in Lisle, Illinois. She has achieved fellow status with both HIMSS and CHIME.
Michael Weintraub
President and CEO
Humedica
Michael is President and CEO of Humedica, a next-generation clinical informatics company. Prior to launching Humedica, Michael served as Senior Managing Director at Leerink Swann, a leading health care investment bank. Previously, he was President and CEO of PHARMetrics, a health care informatics company, which was successfully sold to IMS Health in 2005. Michael has more than 25 years of executive management experience in the health care technology, information services, and consulting arenas. Michael serves as Chairman of the Board of Phreesia, a software company that develops automated patient check-in tools. Michael received his MBA from Harvard Business School and his bachelor’s degree in Economics from Brandeis University.
John Gordon
Partner
Putnam Associates
John Gordon is a Partner at Putnam Associates, a 50-person strategy consulting firm based in Burlington, MA, dedicated to advising the pharmaceutical, biotechnology, diagnostics, and medical device industries on a global basis.
John has been with Putnam Associates since 1992, and has over 20 years of strategy consulting experience. For more than 17 years, he has counseled senior executives at numerous leading pharmaceutical and biotechnology companies, providing strategic support and recommendations on a wide array of issues, including pricing and reimbursement, health economics and outcomes research, new product commercialization, clinical trial development, and sales force optimization strategies. John has extensive experience in specialty pharmaceutical markets that comprise Oncology, Immunology, Cardiovascular Disease, and Anti-Infectives. He is published in peer-review literature as a co-author on a study examining the cost effectiveness of a novel immunological agent used in solid organ transplantation.
Prior to joining Putnam, John worked for an economics consulting firm providing expert testimony in matters of corporate and personal litigation. Currently John serves on the Board of Directors for the National Tay-Sachs & Allied Diseases Association, Inc. John earned a BA in economics summa cum laude from Tufts University and an MBA from Harvard Business School.
Labeeb Abboud
SVP and General Counsel
International AIDS Vaccine Initiative
Labeeb M. Abboud is Senior Vice President and General Counsel of the International AIDS Vaccine Initiative, a non-profit organization whose mission is to ensure the development of safe, effective, accessible, preventive HIV vaccines for use throughout the world. IAVI’s activities include research and development, advocacy and public policy. Its research and development efforts are focused on vaccine development partnerships and research collaborations with biotech and pharmaceutical companies, academic institutions and governments. IAVI is headquartered in New York, with regional offices in Amsterdam, Delhi, Johannesburg and Nairobi. In addition, IAVI operates AIDS vaccine research and development laboratories in New York City, La Jolla, California and London, and supports a network of partner laboratories in the U.S., Europe, Africa and India.
Mr. Abboud is a member of the Senior Management Team, and is responsible for legal, intellectual property and risk management issues, as well as business development activities. He has experience in negotiating collaborations and licensing arrangements with biotech and pharmaceutical companies worldwide and joint ventures with governmental entities. He also advises the board of directors and senior management of IAVI on governance issues. Prior to joining IAVI, Mr. Abboud worked in the fields of international finance, corporate law and microfinance. He serves as a board member of several non-profit organizations in the U.S., Europe and Africa, in the fields of the environment, education and public health. He is a member of the Council on Foreign Relations and is a graduate of Wesleyan University and Georgetown University Law Center.
Sean Maduck
Senior Manager, Market Analysis & Strategy
Genentech
Sean Maduck is a Senior Market Planning Manager in the Industry Analytics group at Genentech, Inc., one of the world’s leading biotechnology companies. Genentech uses human genetic information to discover, develop, manufacture, and commercialize biotherapeutics that address significant unmet medical needs, and in March 2009, Roche Pharmaceuticals based in Basel, Switzerland, acquired the company. In his current role, Sean is responsible for assessing the commercial impact of legislative proposals, generic competition, and the future approval of biosimilars on the Genentech portfolio and the biopharma industry. In addition, he serves as a key liaison with the Roche organization to ensure alignment on key assumptions and analyses across global affiliates, and he helps life-cycle leaders develop value-preserving risk mitigation strategies during life cycle planning. Prior to graduating from the Stanford Graduate School of Business with an MSM in 2009, Sean was a Senior Manager in the Pipeline and Portfolio Planning (PPP) group at Genentech. Over his career at the Company, Sean has built an expertise in cross-functional modeling and system implementation, and has developed valuation and analysis tools for Finance, Business Development, and PPP. Sean has been at Genentech for a total of 7 years, spending his first 4 years in R&D Finance. Before joining Genentech in 2002, Sean was a Senior Investment Banking Analyst with W.R. Hambrecht and Company. He is a Biomedical Engineer, and received both his AB and BE from Dartmouth College. He lives in Burlingame, Calif., with his wife and daughter, and he is an avid hockey player and fan.
Kevin Sheridan
Managing Director, Healthcare Investment Banking
Jefferies & Company
Kevin Sheridan joined Jefferies & Co. in August 2009 as a Managing Director in the Healthcare Investment Banking Group. Prior to joining Jefferies, he was employed at UBS Investment Bank where he served as a Managing Director. Prior to joining UBS, Mr. Sheridan was a Senior Manager with Deloitte Consulting from 1994 to 1999. From 1992 to 1994, Mr. Sheridan was employed by Towers Perrin as an Associate. From 1989 to 1992, Mr. Sheridan was employed by Prudential Healthcare as a Large Case Underwriter. Mr. Sheridan graduated Beta Gamma Sigma from Columbia Business School in 1999 and received his BA from Rutgers University in 1989.
Elizabeth Teisberg
Associate Professor
Darden School of Business, University of Virginia
Dr. Elizabeth Teisberg researches, teaches, and advises executives on strategy and innovation at the Darden School of Business, University of Virginia. Her recent book Redefining Health Care, co-authored with Michael E. Porter, analyzes strategic changes for all participants in the health sector. She is currently working on the implementation of value-based competition on results with employers, hospitals, clinicians, health plans, suppliers and policy makers. Redefining Health Care won the Book of the Year Award from the American College of Healthcare Executives. Professor Teisberg also recently won the Wachovia Award for Outstanding Research and the Frederick S. Morton Award for Leadership. Teisberg serves on three bi-partisan health policy advisory boards and is the author of numerous cases and journal articles. She is a co-author of The Portable MBA, which has been published in five languages. Prior to joining Darden in 1996, Teisberg was a professor in the Strategy Group at the Harvard Business School.
Allan H. Goroll
Physician
Massachusetts General Hospital
Dr. Allan Goroll is a primary care physician at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School. He is one of the modern pioneers in primary care, having initiated the nation’s first residency track in primary care internal medicine at the MGH, where he served his residency. Additionally, Dr. Goroll is the lead author of the first textbook of primary care internal medicine, Primary Care Medicine, now in its 6th edition. In his role as a clinician-educator, he chaired Harvard’s Core Medicine Clerkship and led a national initiative to reform the curriculum of the Core Medicine Clerkship, emphasizing generalist competencies and outpatient training.
He continues to practice and teach primary care internal medicine at the MGH while actively working on health care reform, having founded and now serving as chair emeritus of the Massachusetts eHealth Collaborative and chairing the Massachusetts Coalition for Primary Care Reform. Dr. Goroll has also served as President of the Massachusetts Medical Society and as Massachusetts Governor of the American College of Physicians.
Dr. Goroll recently testified before the U.S. Senate Finance Committee on work-force issues in health care and is currently leading the PCPCC Payment Reform Task Force based in Washington, DC.
Paul D. Mango
Director and Leader, Global Health Care Practice
McKinsey & Company
Paul Mango is a Director in the Pittsburgh office of McKinsey & Company, where he leads the Global Health Care Practice. Paul has led health care engagements spanning strategy, operations, and organization topics, with an emphasis on health reform, the impact of consumer-directed health, development of distinctive service strategies, application of lean manufacturing principles to patient care delivery, and medical tourism. He works with some of the country’s largest health insurers and providers organizations and has spent time serving health care clients in Europe, Asia, and the Middle East.
Recently, Paul co-authored an article for the Wall Street Journal called “The Third Party is Over” discussing Health Savings Accounts; led a research effort and co-authored an article entitled “Consumer-Directed Health Plan Report – Early Evidence is Promising,” that has received national attention; and co-led a McKinsey Global Institute Study on comparative health system reform.
Prior to joining McKinsey in 1988, Paul served five years as a field artillery officer in the U.S. Army. Paul's formal education includes a General Engineering degree from West Point where he graduated as a distinguished cadet in 1981, and a Masters in Business Administration from Harvard University where he graduated as a Baker Scholar in 1988.
Thomas M. Moriarty
General Counsel, Medco Health Solutions
Secretary and SVP, Pharmaceutical Strategies and Solutions
Medco
Mr. Moriarty has served as General Counsel and Secretary since March 2008. In this role, he is responsible for the oversight of all legal, regulatory, public policy and corporate governance functions. In addition, he has served as Senior Vice President, Pharmaceutical Strategies and Solutions since September 2007, with responsibility for relationships with pharmaceutical manufacturers, drug purchasing analysis and consulting with clients on formulary drug lists and plan design. He also served as Senior VP, Business Development responsible for mergers, acquisitions, joint ventures and strategic alliances from August 2006 until March 2008. Prior to that, he was Deputy General Counsel, Vice President and Managing Counsel, responsible for mergers and acquisitions and client and commercial contracting from December 2005 until August 2006. From November 2002 until December 2005, Mr. Moriarty served as Vice President and Counsel, Client Contracting.
Previously, Mr. Moriarty served as Assistant General Counsel, Pharma & North America for Merial Limited (a Merck & Co., Inc. and Sanofi Aventis Company) and as Assistant Counsel for Merck & Co., Inc. Mr. Moriarty received his law degree from the University of Virginia School of Law in 1989 and a bachelor’s degree in Government and Law from Lafayette College in 1985.
Ellen M. Zane
President and CEO
Tufts Medical Center and Floating Hospital for Children
Ellen Zane is the President and CEO of Tufts Medical Center and the Floating Hospital for Children. She is also an Assistant Professor in the Department of Medicine, Division of Clinical Care Research at Tufts University School of Medicine.
From 1994 to 2004, Ellen held the position of Network President for Partners HealthCare System, Inc. In this capacity, she was responsible for the development of a provider network featuring the Massachusetts General Hospital and Brigham & Women's Hospital. Prior to that, Ellen was the CEO at Quincy Hospital in Quincy, MA. At that time, Ellen was an employee of HCA and Quorum Health Resources. Ellen received her BA degree from George Washington University in 1973 and her MA in 1975 from the Catholic University of America in Washington.
Ellen is currently a Director of Parexel International, Fiduciary Trust Company and Century Capital Management. She is a Trustee of Northeastern University and a member of the Health Policy and Management Executive Council at the Harvard School of Public Health. Ellen also is on the Board of Overseers at the Tufts University School of Medicine and is Chair of the Board of the Massachusetts Hospital Association.
Regina Herzlinger
Nancy R. McPherson Professor of Business Administration Chair
Harvard Business School
Regina E. Herzlinger is the Nancy R. McPherson Professor of Business Administration Chair at the Harvard Business School. She was the first woman to be tenured and chaired at Harvard Business School and the first to serve on a number of corporate boards. She is widely recognized for her innovative research in health care, including her early predictions of the unraveling of managed care and the rise of consumer-driven health care and health care focused factories, two terms that she coined. Money has dubbed her the "Godmother" of consumer-driven health care. She was profiled most recently by BusinessWeek in "If Health Care Were Run like Retail" and by Roll Call in "Obama, Congress: Take a Look at the Swiss Answer to Health Care."
Paul Keckley
Executive Director
Deloitte Center for Health Solutions
Paul H. Keckley, Ph.D., is Executive Director for the Deloitte Center for Health Solutions, the health care research arm of Deloitte LLP. The Deloitte Center for Health Solutions’ studies focus on trends and issues in developed and developing systems of care around three major themes: reform of health systems, disruptive innovations that change the structure and performance of systems, and the role of consumers.
Dr. Keckley brings a distinguished 30-year career in health services research in the private sector and academic medicine. He is a health economist and policy expert, and a regular contributor to CNN and Fox News health reform coverage. He is considered one of the country’s leading experts on U.S. health reform.
Prior to joining Deloitte, Dr. Keckley served in leadership roles at Vanderbilt Medical Center including international joint ventures, the Vanderbilt Center for Integrative Health, the health care MBA program launch, and as Executive Director of the Vanderbilt Center for Evidence-based Medicine (VCEBM).
Dr. Keckley completed his BA at Lipscomb University, MA and PhD degrees from Ohio State University, and a fellowship in economic policy at Oxford University. He also enjoys golf and running.
Jim Woodburn
Vice President, Clinical Initiatives
UnitedHealth Group, OptumHealth, ConnectedCare, TeleMedicine
Jim Woodburn, MD, is currently the Vice President of United Health Group’s Clinical Initiatives group. He is involved in the OptumHealth, ConnectedCare and TeleMedicine businesses. Dr. Woodburn is also the President of Woodburn Health Consulting LLC. The consulting practice focuses on transforming health care through accelerating consumer-centric, evidenced-based care and consumer-driven systems change. He is a member of the Lemhi Ventures team as physician advisor, assisting the fund in clinical and care delivery investment decisions and management support. In addition, he is an integral part of Boundary Medical, Inc. leading strategic and operational implementations of clinical outcome measurement and management systems nationwide.
Dr. Woodburn was Chief Medical Officer for MinuteClinic from 2005 to 2007. In his role, he worked with the CEO to develop strategic plans and eventual acquisition by CVS/Caremark Inc. He was also responsible for the clinical integrity and quality for medical care provided by MinuteClinic. He developed new clinical services and strategic relationships with national health systems and providers.
Dr. Woodburn has been a physician since 1984. He trained at the University of Wisconsin-Madison Medical School and has two Bachelor’s degrees in electrical and computer engineering and a Master’s degree in biomedical engineering. He completed his medical residency and academic fellowship in Emergency Medicine at Hennepin County Medical Center in 1988.
Shaun Young
Senior Director, Strategy and Innovation
Walmart Health & Wellness
Shaun Young joined Walmart in 2007 to lead its Health & Wellness Strategy and Innovation. He is responsible for developing and implementing initiatives that lower cost and improve access to healthcare, including Retail Clinics, Multi-Channel Customer Experience, and Merchandise Innovation. Prior to attending business school, Shaun spent 5+ years in diverse healthcare settings including retail, hospital, managed care, patient care, pharmaceuticals, and government. He holds a Doctor of Pharmacy from University of the Pacific (2000) and an MBA from Harvard Business School (2007).
Richard G. Hamermesh
MBA Class of 1961 Professor of Management Practice
Harvard Business School
Richard Hamermesh is the MBA Class of 1961 Professor of Management Practice at the Harvard Business School where he teaches in the MBA Program and is the Faculty Chair of the HBS Healthcare Initiative. Richard created and teaches the second-year MBA elective, Entrepreneurship and Venture Capital in Healthcare. From 1987 to 2001, Richard was a co-founder and Managing Partner of The Center for Executive Development, an executive education and development consulting firm. Prior to this, from 1976 to 1987, he was a member of the faculty at Harvard Business School.
Richard is an active investor and entrepreneur, having participated as principal, director, and investor in the founding and early stages of over 20 organizations, including start-ups, leveraged buy-outs, industry roll-ups, and non-profit foundations. From 1991 to 1996, he was the founding Chairman of Synthes Spine, Inc. Richard is the author or co-author of five books, including New Business Ventures and the Entrepreneur. His best-known book, Fad-Free Management, was published in 1996. Richard received his AB from the University of California and his MBA and DBA from HBS.
Dean Banks
President and CEO
Connective Orthopedics
During his 10+ years in the medical device industry, Dean has been an entrepreneur, investor and operator in medical device companies. Previous work experience includes investor, business development, management and sales roles at Highland Capital Partners, Cytyc Corporation (now Hologic), Cambridge Endoscopic Devices and Ethicon Endo-surgery.
He earned his BA from Miami University, and has an MBA from Harvard Business School. Dean also served four years with the United States Marine Corps.
Christine Bunt
Founder and COO
Taris Biomedical
Christine Bunt is a co-Founder and COO of TARIS Biomedical together with Prof. Michael Cima and Prof. Robert Langer from the Massachusetts Institute of Technology. Prior to founding TARIS, Christine was Vice President of Marketing and Commercial Development at CombinatoRx, Inc. in Cambridge, MA. Prior to CombinatoRx, Christine spent seven years at Merck & Co. in New Jersey where she was leading worldwide commercialization efforts for VIOXX, MAXALT and Cardiovascular Hospital Products. Prior to Merck & Co., Christine assumed various Senior Marketing and Business Management functions at Hoffmann-La Roche in Basel, Switzerland, which included management of Pharmaceutical & Diagnostics products and M&A activities.
Christine earned an MA in Medical Technology and Immunochemistry from the Institute for Hygiene and Infectious Diseases / Medical School of the University of Saarbrücken, Germany.
David Hoffman
SVP, Emerging Business Group
Smith & Nephew Inc.
David Hoffman is Senior Vice President, Business Development & Strategic Planning, for Smith & Nephew’s Advanced Wound Management Division.
Hoffman formerly worked for Boston Scientific Corporation in their Endosurgery Group, where he led their New Market Development and Strategic Planning activity. Prior to his time with BSC, he worked for Baxter Healthcare, primarily in sales and international marketing roles. Hoffman is a member of the Advanced Wound management Global Executive team.
Hoffman holds a BS in Economics from Northwestern University and an MBA from Butler University. He resides in Concord, Mass., with his wife and children.
Mike Hess
Vice President, Innovation Excellence
Medtronic
Mike Hess is the VP of Innovation Excellence at Medtronic. Mike has been at Medtronic for
18 years, beginning as a Biomedical Engineer in the pacemaker research department. He
has also worked in product development, clinical trial management, program management
and product planning marketing. Mike is a Medtronic Technical Fellow, a member of the
Bakken Society, and has about 25 issued patents. He has a BS in biomedical engineering from
Case Western Reserve University and a MS in software engineering from the University of St.
Thomas.
As VP of Innovation Excellence Mike leads the Medtronic R&D council which is primarily
focused on R&D productivity. Mike also leads actives focused on improving the culture of
innovation and collaboration at Medtronic, and serves as the primary sponsor of internal
technical employee organizations.
Frances Toneguzzo
Director, MGH Corporate Sponsored Research & Licensing
Massachusetts General Hospital
Frances is the Director of the MGH Corporate Sponsored Research & Licensing office which oversees the management and licensing of intellectual property and serves as the entry point for all industrial relationships relating to research, support of research or technology transfer at Massachusetts General Hospital. Prior to coming to MGH, Toneguzzo served as Director of the Office for Technology and Industry Collaboration at Tufts University/New England Medical Center and as Associate Director, responsible for intellectual property relating to the life sciences at Harvard University.
Toneguzzo comes from the biotech industry, having played various technical and business development roles at big pharma (E. I Dupont & Co) as well as mid-sized (E.G.&G.Biomolecular) and startup companies (One Cell Systems). She holds a Ph.D. in Biochemistry from McMaster University in Canada.
Yitzhak Zilberman
President and CEO
Bioness Inc.
Mr. Zilberman has been serving as President and CEO of Bioness Inc. – an Alfred Mann company – since its founding in 2004. Bioness Inc. is a Neuromodulation company marketing non-invasive and developing minimally-invasive peripheral neurostimulators intended to treat the tens of millions of individuals suffering from disabling conditions caused by various neurological events and conditions (e.g., stroke and multiple sclerosis), chronic pain and urological syndromes. Bioness now serves its customers throughout the US, Canada, and a number of EU countries. In developing Bioness, Mr. Zilberman has raised over $150 million from investors and assembles a world-class team.
Prior to joining Bioness, Mr. Zilberman was Vice President, Business Development with the Alfred Mann Foundation in Valencia, CA. His prior experience includes various managerial positions with MiniMed Inc., Advanced Bionics and its European subsidiary, Advanced Bionics SARL. Prior to working for Alfred Mann companies, Mr. Zilberman served 14 years in the Israeli Defense Forces Intelligence Corps, concluding his service as a Major, during which time his team won the Israel Defense Award. Yitzhak has degrees in Computer Science and Archeology from Bar Ilan University in Israel (magna cum laude) and he is a graduate of the UCLA Anderson School of Management Executive Program.